About Anivive
Anivive is a Healthcare company based in Long Beach (United States) founded in 2015 by Dylan Balsz. It operates as a therapeutics for animal health, including oncology and endocrines, are developed. Anivive has raised $44.3 million across 4 funding rounds from investors including HHS, LEONID and U.S. Food and Drug Administration. The company has 22 employees. Its chief executive is Dylan Balsz. Its website anivive.com draws about 11 thousand monthly visits. Anivive offers products and services including SearchLight DNA, Valley Fever Vaccine, FIP Treatments, and AI Imaging. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals. Its competitors include Invetx, Vétoquinol, Aratana Therapeutics, Gallant and HIPRA and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Anivive was founded in 2015 in Long Beach, United States, and operates in the animal health sector. Therapeutics for pets are developed, with the lead product Laverdia targeted at lymphoma in dogs. Additional products include five endocrines, three oncologic treatments, two for infectious diseases, and four others. A software solution for identifying medicines and adverse effects has also been created.
- Headquarters Long Beach, United States
- Employees 22
- Founders Dylan Balsz
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website anivive.com
- Social LinkedIn Facebook Instagram
- Total Equity Funding$44.3M (USD)
in 4 rounds
- Latest Funding Round$20M (USD), Debt – Conventional
Jan 2025
- InvestorsHHS
& 2 more
- Employee Count22
Products & Services of Anivive
Anivive offers a comprehensive portfolio of products and services, including SearchLight DNA, Valley Fever Vaccine, FIP Treatments, and AI Imaging.
Provides next-generation genotyping for personalized pet cancer treatments.
Develops vaccine against fungal infections in dogs.
Offers biologics for feline infectious peritonitis management.
Detects fungal infections via x-ray analysis for pets.
Funding Insights of Anivive
Anivive has successfully raised a total of $44.3M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.3M
- Total Rounds 4
- Last Round Debt – Conventional — $20M
- First Round $500,000
(Jun 2020)
- Investors Count 3
All 4 funding rounds of Anivive with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Anivive
Anivive has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, LEONID and U.S. Food and Drug Administration.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of financial services | 2019 | leonidfinance.io | Huntington Beach, United States | |
The U.S. Food and Drug Administration is tasked with regulating food, drugs, and medical products. | – | fda.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Anivive
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Anivive
16 people are tracked at Anivive (8 in leadership, 7 in board & advisors, 1 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Dylan Balsz | Founder & CEO | Leadership |
Cody Arbuckle | Chief Technology Officer | Leadership |
David Bruyette | Chief Medical Officer | Leadership |
Brooklyn Jenkins | Head Laboratory Technician | Leadership |
Chad Dodd | Chief Commercial Officer | Leadership |
Trudy Yin | Vice President, Quality Assurance | Leadership |
Dr. Julie Dinnage | Director, Veterinary Medical Affairs | Leadership |
Cheryl Collett | Chief Financial Officer | Leadership |
Robert Bishop | Board Member | Board & advisors |
Gavin Herbert | Advisor | Board & advisors |
Lynne Doti | Board Member | Board & advisors |
Peter Carlsson | Advisor | Board & advisors |
David Pyott | Advisor | Board & advisors |
Glenn Stearns | Board Member | Board & advisors |
James Beaubien | Board Member | Board & advisors |
Skyler Stearns | Software Developer | Team |
Complete people profiles for Anivive
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Anivive
3 dated milestones of Anivive across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Anivive is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Debt – Conventional, of $20.0M.
Competitors of Anivive
Anivive has 9 listed competitors in our database, 6 of them funded. They include Invetx, Vétoquinol, Aratana Therapeutics, Gallant and HIPRA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invetx.com | 2018 | Boston, United States | $86M | – | Provider of pharmaceutical products like protein-based therapeutics for pets | |
| vetoquinol.com | 1933 | Lure, France | – | – | Therapeutics drugs for animal health are developed and formulated. | |
| aratanatherapeutics.com | 2010 | Kansas, United States | $76.75M | 83 | Develops innovative small molecules and biologics for companion animal diseases. | |
| gallant.com | 2018 | Los Angeles, United States | $61.46M | – | Stem cell storage for canine regenerative therapy is offered. | |
| hipra.com | 1996 | Amer, Spain | – | 8 | Vaccines and diagnostic kits for animal diseases are developed. | |
| genvax.com | 2021 | Ames, United States | $9.9M | – | Vaccines for animal diseases are developed using mRNA nanoparticles. | |
| loyal.app | 2020 | Encinitas, United States | $31.97M | – | Mobile application development, data management, and advertising services are provided. | |
| intervacc.se | 2001 | Stockholm, Sweden | – | – | Recombinant vaccines for cattle, equine, and other livestock are developed. | |
| eqcell.com | 2010 | Guelph, Canada | $4.6M | 8 | Stem cell therapies for animal health are developed. |
Detailed competitors of Anivive
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Anivive
The website of Anivive (anivive.com) receives about 10.9K visits a month.
- Monthly visits10.9K
▲ 24.9% vs previous month
Websites whose visitors overlap most with Anivive. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
spep.com | spep.com | 100% | – | #2,335,895 | – |
snydermanufacturing.com | snydermanufacturing.com | 100% | – | – | – |
| thepkgco.com | 99% | 5.9K | #3,348,326 | View details | |
braggcompanies.com | braggcompanies.com | 98% | – | #3,910,787 | – |
| royal4.com | 87% | – | #2,782,714 | View details |
Top companies in Veterinary Digital Health
10 companies that operate in the same segment as Anivive (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Anivive
Complete news archive for Anivive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anivive
Anivive was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Anivive is headquartered in Long Beach, United States. It is registered at Long Beach, California, United States.
Dylan Balsz is the current CEO of Anivive. They have also founded this company.
Anivive is a funded company, having raised a total of $44.3M across 4 funding rounds to date. The company's 1st funding round was a Grant of $500K, raised on Jun 2020.
Anivive has 22 employees.
Anivive was founded in 2015 in Long Beach, United States, and operates in the animal health sector. Therapeutics for pets are developed, with the lead product Laverdia targeted at lymphoma in dogs. Additional products include five endocrines, three oncologic treatments, two for infectious diseases, and four others. A software solution for identifying medicines and adverse effects has also been created.
Anivive offers SearchLight DNA, Valley Fever Vaccine, FIP Treatments, and AI Imaging.
Anivive has 3 investors. Key investors include HHS, LEONID, and U.S. Food and Drug Administration.